mapping the effectiveness and risks of glp-1 receptor agonists pdf Cardiovascular Protective Properties Agonists: More than Just Diabetic Weight Loss Drugs Understanding the risk of diabetic

BI 456906: discovery and preclinical pharmacology of a novel GCGR/GLP-1R dual agonist with robust anti-obesity efficacy

23 Recent research points to the potential of GLP-1RAs as a therapeutic solution in treating IBD

In addition to their glycemic effects, DPP-4 inhibitors have the potential to decrease bone resorption, increase bone formation, and reduce the incidence of osteoporosis and fractures

Noronha, M., Souza, M

48 h) significantly reduces high glucose (HG)-stimulated production of fibronectin, collagen type IV, and -smooth muscle actin in human mesangial cells

Across published trials, better adherence to injectable medications was generally found to be associated with improved glycemic control (46)